583 related articles for article (PubMed ID: 15347171)
1. [A randomized comparison of carvedilol and metoprolol in patients with chronic heart failure. The Carvedilol Or Metoprolol European Trial (COMET) ].
Torp-Pedersen CT;
Ugeskr Laeger; 2004 Aug; 166(32):2671-4. PubMed ID: 15347171
[No Abstract] [Full Text] [Related]
2. The COMET trial.
Bristow MR; Adams KF; Bauman JL; Feldman AM; Giles TD; Goldstein S; Mann DL; Talbert RL
Congest Heart Fail; 2005; 11(1):39-47. PubMed ID: 15722669
[No Abstract] [Full Text] [Related]
3. [Therapy of chronic heart failure--carvedilol vs. metoprolol. COMET Study].
Ertl G; Nitschmann S
Internist (Berl); 2004 Jul; 45(7):835-6. PubMed ID: 15054581
[No Abstract] [Full Text] [Related]
4. [The COMET study compares effect of two different beta-blockers in chronic heart failure. Carvedilol better than metoprolol].
Swedberg K
Lakartidningen; 2003 Sep; 100(37):2852-4. PubMed ID: 14558169
[No Abstract] [Full Text] [Related]
5. Effects of metoprolol and carvedilol on pre-existing and new onset diabetes in patients with chronic heart failure: data from the Carvedilol Or Metoprolol European Trial (COMET).
Torp-Pedersen C; Metra M; Charlesworth A; Spark P; Lukas MA; Poole-Wilson PA; Swedberg K; Cleland JG; Di Lenarda A; Remme WJ; Scherhag A;
Heart; 2007 Aug; 93(8):968-73. PubMed ID: 17237130
[TBL] [Abstract][Full Text] [Related]
6. [A fairer comparison between carvedilol and metoprolol is still to be done].
Johnsson G; Aberg J
Lakartidningen; 2003 Oct; 100(44):3543-4, 3544-5. PubMed ID: 14651018
[No Abstract] [Full Text] [Related]
7. Exchange of beta-blockers in heart failure patients. Experiences from the poststudy phase of COMET (the Carvedilol or Metoprolol European Trial).
Di Lenarda A; Remme WJ; Charlesworth A; Cleland JG; Lutiger B; Metra M; Komajda M; Torp-Pedersen C; Scherhag A; Swedberg K; Poole-Wilson PA;
Eur J Heart Fail; 2005 Jun; 7(4):640-9. PubMed ID: 15921806
[TBL] [Abstract][Full Text] [Related]
8. [Beta blockers for therapy of chronic heart failure].
Murakami T
Nihon Naika Gakkai Zasshi; 2005 Feb; 94(2):248-54. PubMed ID: 15768588
[No Abstract] [Full Text] [Related]
9. Has COMET solved the controversy as to whether carvedilol is better than metoprolol in heart failure?
Doggrell SA
Expert Opin Pharmacother; 2004 Jan; 5(1):205-8. PubMed ID: 14680448
[TBL] [Abstract][Full Text] [Related]
10. Effects of carvedilol or metoprolol on PAI-1, tPA-mass concentration or Von Willebrand factor in chronic heart failure--a COMET substudy.
Boman K; Jansson JH; Nilsson T; Swedberg K; Cleland JG; Poole-Wilson P
Thromb Res; 2010 Feb; 125(2):e46-50. PubMed ID: 19762071
[TBL] [Abstract][Full Text] [Related]
11. Commentary on the Carvedilol or Metoprolol European Trial (COMET).
Poole-Wilson PA
Am J Cardiol; 2004 May; 93(9A):40B-2B. PubMed ID: 15144936
[TBL] [Abstract][Full Text] [Related]
12. Carvedilol in the treatment of chronic heart failure: lessons from the Carvedilol Or Metoprolol European Trial.
Kveiborg B; Major-Petersen A; Christiansen B; Torp-Pedersen C
Vasc Health Risk Manag; 2007; 3(1):31-7. PubMed ID: 17583173
[TBL] [Abstract][Full Text] [Related]
13. [For the first time beta blockers are in direct comparison With carvedilol weak hearts beat longer].
MMW Fortschr Med; 2003 Jul; 145(27-28):60. PubMed ID: 14587195
[No Abstract] [Full Text] [Related]
14. Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol Or Metoprolol European Trial (COMET): randomised controlled trial.
Poole-Wilson PA; Swedberg K; Cleland JG; Di Lenarda A; Hanrath P; Komajda M; Lubsen J; Lutiger B; Metra M; Remme WJ; Torp-Pedersen C; Scherhag A; Skene A;
Lancet; 2003 Jul; 362(9377):7-13. PubMed ID: 12853193
[TBL] [Abstract][Full Text] [Related]
15. Effects of metoprolol and carvedilol on cause-specific mortality and morbidity in patients with chronic heart failure--COMET.
Torp-Pedersen C; Poole-Wilson PA; Swedberg K; Cleland JG; Di Lenarda A; Hanrath P; Komajda M; Lutiger B; Metra M; Remme WJ; Scherhag A; Skene A;
Am Heart J; 2005 Feb; 149(2):370-6. PubMed ID: 15846279
[TBL] [Abstract][Full Text] [Related]
16. Comprehensive adrenergic receptor blockade with carvedilol is superior to beta-1-selective blockade with metoprolol in patients with heart failure: COMET.
Cleland JG
Curr Heart Fail Rep; 2004 Jul; 1(2):82-8. PubMed ID: 16036030
[TBL] [Abstract][Full Text] [Related]
17. Carvedilol and metoprolol European trial: do the results merit challenge?
Smith KM
Am J Health Syst Pharm; 2004 Jun; 61(12):1289-93. PubMed ID: 15259762
[No Abstract] [Full Text] [Related]
18. Pharmacodynamics of beta-blockers in heart failure: lessons from the carvedilol or metoprolol European trial.
Bauman JL; Talbert RL
J Cardiovasc Pharmacol Ther; 2004 Jun; 9(2):117-28. PubMed ID: 15309248
[TBL] [Abstract][Full Text] [Related]
19. Comparison of safety and efficacy of carvedilol and metoprolol in stable angina pectoris.
van der Does R; Hauf-Zachariou U; Pfarr E; Holtbrügge W; König S; Griffiths M; Lahiri A
Am J Cardiol; 1999 Mar; 83(5):643-9. PubMed ID: 10080412
[TBL] [Abstract][Full Text] [Related]
20. [Comparative study in heart failure. Which beta blocker saves more life time?].
MMW Fortschr Med; 2003 Oct; 145(40):52. PubMed ID: 14603606
[No Abstract] [Full Text] [Related]
[Next] [New Search]
